Cytokinetics Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€30.20
Target price
04.08.24
€54.39
Performance (%)
67.22%
End price
05.08.24
€50.50
Summary
This prediction ended on 05.08.24 with a price of €50.50. With a performance of 67.22% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytokinetics Inc. | 1.463% | 1.463% | 104.294% | 119.079% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% | 65.211% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% | 90.325% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% | 80.623% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% | 70.737% |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Cytokinetics Inc.
Stopped prediction by Morgan_Stanley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.00
13.02.25
13.02.25
€64.45
13.02.26
13.02.26
35.37%
14.02.26
14.02.26
